Barriers to and facilitators of adherence to pediatric antiretroviral therapy in a sub-Saharan setting: Insights from a qualitative study

AIDS Patient Care and STDs

Volumn 25, Issue 10, 2011, Pages 611-621

  Fetzer, Bradley C ^a,b   Mupenda, Bavon ^c   Lusiama, Jean ^c,d   Kitetele, Faustin ^c,d   Golin, Carol ^b   Behets, Frieda ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c Kinshasa School of Public Health   (Congo)

^d Kalembe Lembe Pediatric Hospital   (Congo)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; NEVIRAPINE; ZIDOVUDINE;

ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; ARTICLE; CAREGIVER; CAREGIVER CHILD RELATIONSHIP; CAREGIVER SUPPORT; CHILD; CHILD CARE; CHILD NUTRITION; CLINICAL ARTICLE; CONTROLLED STUDY; EVENING DOSAGE; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN RELATION; INTERPERSONAL COMMUNICATION; MALE; MORNING DOSAGE; NUTRITIONAL SUPPORT; PATIENT COMPLIANCE; PSYCHOSOCIAL CARE; QUALITATIVE RESEARCH; SCHOOL CHILD; STOMACH IRRITATION;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; CAREGIVERS; CHILD; DEMOCRATIC REPUBLIC OF THE CONGO; FEMALE; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; MALE; MEDICATION ADHERENCE; MIDDLE AGED; QUALITATIVE RESEARCH; SOCIAL SUPPORT; STEREOTYPING; TRUTH DISCLOSURE;

EID: 80053422683     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2011.0083     Document Type: Article

References (29)

1. Joint United Nations Program on HIV/AIDS, World Health Organization. AIDS epidemic update: December 2009. Geneva: 2009.
2. Callens SF, Shabani N, Lusiama J, et al. Mortality and associated factors after initiation of pediatric antiretroviral treatment in the Democratic Republic of the Congo. Pediatr Infect Dis J 2009;28:35-40.
3. Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. February 23, 2009; pp 1-139. http://aidsinfo.nih.gov/ ContentFiles/PediatricGuidelines.pdf (Last accessed June 23, 2010).
4. Paterson D, Swindells S, Mohr J, et al. How much adherence is enough? A prospective study of adherence to protease inhibitor therapy using MEMSCaps [Abstract 92]. In: Conference on Retroviruses and Opportunistic Infections. Pittsburgh, PA: January 31 to February 4, 1999.
5. Mullen J, Leech S, O'Shea S, et al. Antiretroviral drug resistance among HIV-1 infected children failing treatment. J Med Virol 2002;3:299-304.
6. Shekelle P, Maglione M, Geotz MB, et al. Antiretroviral (ARV) drug resistance in the developing world. Evid Rep Technol Assess (Full Rep) 2007;156:1-74.
7. Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14: 357-366. (Pubitemid 30182431)
8. Maggiolo F, Airoldi M, Kleinloog HD, et al. Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI- or PI-treated patients. HIV Clin Trials 2007;8:282-292. (Pubitemid 350099562)
9. Chalker J, Andualem T, Minzi O, et al. Monitoring adherence and defaulting for antiretroviral therapy in 5 east African countries: An urgent need for standards. J Int Assoc Physicians AIDS Care (Chic Ill) 2008;7:193-199.
10. Puigventos F, Riera M, Delibes C, Penaranda M, de la Fuente L, Boronat A. Adherence to antiretroviral drug therapy: A systematic review. Med Clin (Barc) 2002;119: 130-137. (Pubitemid 35256342)
11. Sankar A, Golin C, Simoni JM, Luborsky M, Pearson C. How qualitative methods contribute to understanding combination antiretroviral therapy adherence. J Acquir Immune Defic Syndr 2006;43(Suppl 1):S54-68. (Pubitemid 44885643)
12. Vreeman RC, Wiehe SE, Pearce EC, Nyandiko WM. A systematic review of pediatric adherence to antiretroviral therapy in low- and middle-income countries. Pediatr Infect Dis J 2008;27:686-691.
13. Haberer J, Mellins C. Pediatric adherence to HIV antiretroviral therapy. Curr HIV/AIDS Rep 2009;6:194-200.
14. Bikaako-Kajura W, Luyirika E, Purcell DW, et al. Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS Behav 2006;10: S85-93.
15. Vreeman RC, Nyandiko WM, Ayaya SO, Walumbe EG, Marrero DG, Inui TS. Factors sustaining pediatric adherence to antiretroviral therapy in Western Kenya. Qual Health Res 2009;19:1716-1729.
16. Makoae MG, Jubber K. Confidentiality or continuity? Family caregivers' experiences with care for HIV/AIDS patients in home-based care in Lesotho. Sahara J 2008;5:36-46.
17. Merzel C, Vandevanter N, Irvine M. Adherence to antiretroviral therapy among older children and adolescents with HIV: A qualitative study of psychosocial contexts. AIDS Patient Care STDs 2008;22:977-987.
18. Roura M, Busza J, Wringe A, Mbata D, Urassa M, Zaba B. Barriers to sustaining antiretroviral treatment in Kisesa, Tanzania: A follow-up study to understand attrition from the antiretroviral program. AIDS Patient Care STDs 2009;23: 203-210.
19. Abadia-Barrero CE, Castro A. Experiences of stigma and access to HAART in children and adolescents living with HIV/AIDS in Brazil. Soc Sci Med 2006;62:1219-1228. (Pubitemid 43136466)
20. Patton MQ. Qualitative Research and Evaluation Methods, 3rd ed. Thousand Oaks, CA: Sage Publications, 2001.
21. Vaz L, Corneli A, Dulyx J, et al. The process of HIV status disclosure to HIV-positive youth in kinshasa, democratic republic of the congo. AIDS Care 2008;20:842-852.
22. Petersen I, Bhana A, Myeza N, et al. Psychosocial challenges and protective influences for socio-emotional coping of HIV + adolescents in South Africa: A qualitative investigation. AIDS Care 2010;12:1-9.
23. Joint United Nations Program on HIV/AIDS, 2008. Children and AIDS second stocktaking report. http://data.unaids.org/ pub/Report/2008/ childrenandaidssecondstocktakingreport- en.pdf (Last accessed February 24, 2010).
24. Hammami N, Nostlinger C, Hoeree T, et al. Integrating adherence to highly active antiretroviral therapy into children's daily lives: A qualitative study. Pediatrics 2004;114: e591-597. (Pubitemid 41647667)
25. Biadgilign S, Deribew A, Amberbir A, Deribe K. Barriers and facilitators to antiretroviral medication adherence amongHIV-infected paediatric patients in Ethiopia: A qualitative study. J Soc Aspects of HIV/AIDS 2009;6:148-154.
26. World Health Organization. WHO Global Database on Child Growth and Malnutrition-Democratic Republic of the Congo: March 2009. www.who.int/entity/ nutgrowthdb/ database/countries/who-standards/cod.pdf (Last accessed September 21, 2010).
27. Levine AJ, Hinkin CH, Marion S, et al. Adherence to antiretroviral medications in HIV: Differences in data collected via self-report and electronic monitoring. Health Psychol 2006;25:329-335. (Pubitemid 44128262)
28. Muller AD, Bode S, Myer L, Roux P, von Steinbuchel N. Electronic measurement of adherence to pediatric antiretroviral therapy in South Africa. Pediatric Infect Dis J 2008;27:257-262.
29. Miller LG, Liu H, Hays RD, et al. How well do clinicians estimate patients' adherence to combination antiretroviral therapy? J Gen Intern Med 2002;17:1-11. (Pubitemid 34117786)